Galantamine Causes Weight Loss and Improves Glycemic Control in Diabetic Mice
Obesity-related inflammation contributes to the pathogenesis of type 2 diabetes mellitus (T2DM). Galantamine activates the vagal-mediated cholinergic anti-inflammatory pathway (CAP). We hypothesize that galantamine will decrease food intake, body weight and improve glycemic control in the obese (db/db) mouse model.
Source: Journal of the American College of Surgeons - Category: Surgery Authors: Napat Pruekprasert, Qinghe Meng, Han Xie, Robert Nickerson Cooney Tags: Bariatric and foregut Source Type: research
More News: Bariatric Surgery | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Men | Obesity | Surgery | Weight Loss